cancer, heart failure)
Why no clinical drug development DSIP has not progressed through controlled clinical drug development, and the reasons map directly onto the issues discussed above: No identified receptor
Yes, for some individuals, a combined approach of B12 injections and tablets, or transitioning from injections to high-dose oral supplements for maintenance, is a viable and effective strategy
A single B12 shot continues to deliver benefits for roughly two to four weeks, with peak effects in the first week and a gradual taper after
Individual results vary based on numerous factors including genetics, adherence, product quality, and overall health status.
The Morris Water Maze task served as the primary behavioral assessment, involving 8 days of training with 5 trials per day